Hong Kong Pharma Stock Performance
| HKPD Stock | 0.80 0.05 6.67% |
The company retains a Market Volatility (i.e., Beta) of 1.54, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Hong Kong will likely underperform. At this point, Hong Kong Pharma has a negative expected return of -0.82%. Please make sure to check out Hong Kong's value at risk, as well as the relationship between the accumulation distribution and day typical price , to decide if Hong Kong Pharma performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Hong Kong Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in January 2026. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders. ...more
| Begin Period Cash Flow | 627.3 K | |
| Total Cashflows From Investing Activities | -2.5 M |
Hong Kong Relative Risk vs. Return Landscape
If you would invest 161.00 in Hong Kong Pharma on September 28, 2025 and sell it today you would lose (81.00) from holding Hong Kong Pharma or give up 50.31% of portfolio value over 90 days. Hong Kong Pharma is currently does not generate positive expected returns and assumes 8.0044% risk (volatility on return distribution) over the 90 days horizon. In different words, 71% of stocks are less volatile than Hong, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Hong Kong Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Hong Kong's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Hong Kong Pharma, and traders can use it to determine the average amount a Hong Kong's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.103
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | HKPD |
Based on monthly moving average Hong Kong is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Hong Kong by adding Hong Kong to a well-diversified portfolio.
Hong Kong Fundamentals Growth
Hong Stock prices reflect investors' perceptions of the future prospects and financial health of Hong Kong, and Hong Kong fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Hong Stock performance.
| Return On Equity | -0.0059 | ||||
| Return On Asset | 0.0132 | ||||
| Profit Margin | (0) % | ||||
| Operating Margin | (0.09) % | ||||
| Current Valuation | 7.62 M | ||||
| Shares Outstanding | 11 M | ||||
| Price To Book | 1.65 X | ||||
| Price To Sales | 0.41 X | ||||
| Revenue | 20.31 M | ||||
| EBITDA | 1.21 M | ||||
| Total Debt | 2.37 M | ||||
| Book Value Per Share | 0.45 X | ||||
| Cash Flow From Operations | 569.21 K | ||||
| Total Asset | 9.42 M | ||||
| Retained Earnings | 1.5 M | ||||
About Hong Kong Performance
By analyzing Hong Kong's fundamental ratios, stakeholders can gain valuable insights into Hong Kong's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Hong Kong has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Hong Kong has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Things to note about Hong Kong Pharma performance evaluation
Checking the ongoing alerts about Hong Kong for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Hong Kong Pharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Hong Kong Pharma generated a negative expected return over the last 90 days | |
| Hong Kong Pharma has high historical volatility and very poor performance | |
| Hong Kong Pharma has some characteristics of a very speculative penny stock | |
| The company reported the previous year's revenue of 20.31 M. Net Loss for the year was (27.06 K) with profit before overhead, payroll, taxes, and interest of 2.42 M. | |
| Hong Kong Pharma has a strong financial position based on the latest SEC filings |
- Analyzing Hong Kong's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Hong Kong's stock is overvalued or undervalued compared to its peers.
- Examining Hong Kong's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Hong Kong's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Hong Kong's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Hong Kong's stock. These opinions can provide insight into Hong Kong's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Hong Stock analysis
When running Hong Kong's price analysis, check to measure Hong Kong's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hong Kong is operating at the current time. Most of Hong Kong's value examination focuses on studying past and present price action to predict the probability of Hong Kong's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hong Kong's price. Additionally, you may evaluate how the addition of Hong Kong to your portfolios can decrease your overall portfolio volatility.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| CEOs Directory Screen CEOs from public companies around the world |